Medtronic, Inc. Stock Nyse
Equities
US5850551061
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
||
- USD | - |
Apr. 26 | Medtronic Receives FDA Approval for Inceptiv Spinal Cord Stimulator to Treat Chronic Pain | MT |
Apr. 26 | Medtronic Gets FDA OK for Inceptiv Closed-Loop Spinal Cord Stimulator | DJ |
Financials (USD)
Sales 2024 * | 32.24B | Sales 2025 * | 33.57B | Capitalization | 106B |
---|---|---|---|---|---|
Net income 2024 * | 4.55B | Net income 2025 * | 5.24B | EV / Sales 2024 * | 3.98 x |
Net Debt 2024 * | 22.3B | Net Debt 2025 * | 21.07B | EV / Sales 2025 * | 3.78 x |
P/E ratio 2024 * |
22.8
x | P/E ratio 2025 * |
19.7
x | Employees | - |
Yield 2024 * |
3.45% | Yield 2025 * |
3.63% | Free-Float | 99.82% |
Latest transcript on Medtronic, Inc.
Managers | Title | Age | Since |
---|---|---|---|
Geoffrey Martha
CEO | Chief Executive Officer | 54 | 15-01-25 |
Karen Parkhill
DFI | Director of Finance/CFO | 58 | 16-05-31 |
Gregory Smith
COO | Chief Operating Officer | 60 | 21-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Scott Donnelly
BRD | Director/Board Member | 62 | 12-12-31 |
Kendall Powell
BRD | Director/Board Member | 70 | 06-12-31 |
Randall Hogan
BRD | Director/Board Member | 68 | 14-12-31 |
1st Jan change | Capi. | |
---|---|---|
-2.31% | 187B | |
-5.04% | 66.9B | |
+0.20% | 49.45B | |
+17.29% | 48B | |
+4.06% | 40.84B | |
+2.36% | 26.25B | |
+2.07% | 26.48B | |
+12.96% | 24.62B | |
-1.93% | 24.52B |